Intrinsic Value

The intrinsic value of Pediatrix Medical Group Inc (PDC) under the Base Case is 83.34 EUR per share. Compared with the current market price of 26 EUR, the stock appears Undervalued by 69% .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

PDC Intrinsic Value
€83.34
Undervaluation 69%
Intrinsic Value
Price €26

PDC is more expensive than usual. Still undervalued, but the discount was larger on 95% of days in the past 5 years.

Monitor PDC
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value €66.67
Get notified when the price drops into your buy zone
Intrinsic Value €83.34
Margin of Safety 20% €66.67
Current Price €26
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to PDC

Fundamental Analysis

What Pediatrix Medical Group Does

Health Care

Pediatrix Medical Group is a physician services company that focuses on caring for newborns, mothers with high-risk pregnancies, and children with special medical needs. It places doctors and advanced practice clinicians in hospitals and clinics, with a strong focus on neonatal intensive care, maternal-fetal medicine, and other pediatric subspecialties. In simple terms, it helps hospitals staff specialized medical teams where expert care is needed around childbirth and early childhood.

Headquarters
United States of America US
Employees
2 800
IPO date
Sep 20, 1995
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Pediatrix Medical Group Inc

Wall St Price Targets

Capital Returns

Competitive Landscape

Ownership

MD Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one PDC stock?

The intrinsic value for Pediatrix Medical Group Inc (PDC) under the Base Case is 83.34 EUR.

Is PDC stock undervalued or overvalued?

Compared with the current market price of 26 EUR, the stock appears Undervalued by 69% .

Back to Top